{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T12:14:26Z","timestamp":1725797666922},"reference-count":3,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1097\/01.chi.0000173296.06761.9e","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T11:04:14Z","timestamp":1121166254000},"page":"726-727","source":"Crossref","is-referenced-by-count":1,"title":["OLANZAPINE IN RETT'S DISORDER"],"prefix":"10.1016","volume":"44","author":[{"given":"Daniel","family":"Bober","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Robin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi E.","family":"Star","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/01.chi.0000173296.06761.9e_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/026988110201600113","article-title":"A systematic review of the use of atypical antipsychotics in autism","volume":"16","author":"Barnard","year":"2002","journal-title":"J Psychopharmacol"},{"key":"10.1097\/01.chi.0000173296.06761.9e_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-200210000-00003","article-title":"Open-label study of olanzapine in children with pervasive developmental disorder","volume":"22","author":"Kemner","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1097\/01.chi.0000173296.06761.9e_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004714-199902000-00008","article-title":"Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study","volume":"19","author":"Potenza","year":"1999","journal-title":"J Clin Psychopharmacol"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709617330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709617330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T14:38:44Z","timestamp":1568212724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709617330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":3,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0890856709617330"],"URL":"https:\/\/doi.org\/10.1097\/01.chi.0000173296.06761.9e","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}